Docosahexaenoic Acid and Melatonin Prevent Impaired Oligodendrogenesis Induced by Intrauterine Growth Restriction (IUGR)

In this study, our aims were to characterize oligodendrogenesis alterations in fetuses with intrauterine growth restriction (IUGR) and to find therapeutic strategies to prevent/treat them using a novel rabbit in vitro neurosphere culture. IUGR was surgically induced in one uterine horn of pregnant r...

Full description

Bibliographic Details
Main Authors: Britta Anna Kühne, Paula Vázquez-Aristizabal, Mercè Fuentes-Amell, Laura Pla, Carla Loreiro, Jesús Gómez-Catalán, Eduard Gratacós, Miriam Illa, Marta Barenys
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/10/5/1205
_version_ 1797501315669032960
author Britta Anna Kühne
Paula Vázquez-Aristizabal
Mercè Fuentes-Amell
Laura Pla
Carla Loreiro
Jesús Gómez-Catalán
Eduard Gratacós
Miriam Illa
Marta Barenys
author_facet Britta Anna Kühne
Paula Vázquez-Aristizabal
Mercè Fuentes-Amell
Laura Pla
Carla Loreiro
Jesús Gómez-Catalán
Eduard Gratacós
Miriam Illa
Marta Barenys
author_sort Britta Anna Kühne
collection DOAJ
description In this study, our aims were to characterize oligodendrogenesis alterations in fetuses with intrauterine growth restriction (IUGR) and to find therapeutic strategies to prevent/treat them using a novel rabbit in vitro neurosphere culture. IUGR was surgically induced in one uterine horn of pregnant rabbits, while the contralateral horn served as a control. Neural progenitor cells (NPCs) were obtained from pup’s whole brain and cultured as neurospheres mimicking the basic processes of brain development including migration and cell differentiation. Five substances, chosen based on evidence provided in the literature, were screened in vitro in neurospheres from untreated rabbits: Docosahexaenoic acid (DHA), melatonin (MEL), zinc, 3,3′,5-Triiodo-L-thyronine (T3), and lactoferrin (LF) or its metabolite sialic acid (SA). DHA, MEL and LF were further selected for in vivo administration and subsequent evaluation in the Neurosphere Assay. In the IUGR culture, we observed a significantly reduced percentage of oligodendrocytes (OLs) which correlated with clinical findings indicating white matter injury in IUGR infants. We identified DHA and MEL as the most effective therapies. In all cases, our in vitro rabbit neurosphere assay predicted the outcome of the in vivo administration of the therapies and confirmed the reliability of the model, making it a powerful and consistent tool to select new neuroprotective therapies.
first_indexed 2024-03-10T03:16:38Z
format Article
id doaj.art-8568f33437da42e3a95fe1b065de0e7a
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-10T03:16:38Z
publishDate 2022-05-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-8568f33437da42e3a95fe1b065de0e7a2023-11-23T10:12:34ZengMDPI AGBiomedicines2227-90592022-05-01105120510.3390/biomedicines10051205Docosahexaenoic Acid and Melatonin Prevent Impaired Oligodendrogenesis Induced by Intrauterine Growth Restriction (IUGR)Britta Anna Kühne0Paula Vázquez-Aristizabal1Mercè Fuentes-Amell2Laura Pla3Carla Loreiro4Jesús Gómez-Catalán5Eduard Gratacós6Miriam Illa7Marta Barenys8Grup de Recerca en Toxicologia (GRET), INSA-UB and Toxicology Unit, Pharmacology, Toxicology and Therapeutical Chemistry Department, Faculty of Pharmacy, University of Barcelona, 08028 Barcelona, SpainGrup de Recerca en Toxicologia (GRET), INSA-UB and Toxicology Unit, Pharmacology, Toxicology and Therapeutical Chemistry Department, Faculty of Pharmacy, University of Barcelona, 08028 Barcelona, SpainGrup de Recerca en Toxicologia (GRET), INSA-UB and Toxicology Unit, Pharmacology, Toxicology and Therapeutical Chemistry Department, Faculty of Pharmacy, University of Barcelona, 08028 Barcelona, SpainBCNatal | Fetal Medicine Research Center (Hospital Clínic and Hospital Sant Joan de Déu), Universitat de Barcelona, 08028 Barcelona, SpainBCNatal | Fetal Medicine Research Center (Hospital Clínic and Hospital Sant Joan de Déu), Universitat de Barcelona, 08028 Barcelona, SpainGrup de Recerca en Toxicologia (GRET), INSA-UB and Toxicology Unit, Pharmacology, Toxicology and Therapeutical Chemistry Department, Faculty of Pharmacy, University of Barcelona, 08028 Barcelona, SpainBCNatal | Fetal Medicine Research Center (Hospital Clínic and Hospital Sant Joan de Déu), Universitat de Barcelona, 08028 Barcelona, SpainBCNatal | Fetal Medicine Research Center (Hospital Clínic and Hospital Sant Joan de Déu), Universitat de Barcelona, 08028 Barcelona, SpainGrup de Recerca en Toxicologia (GRET), INSA-UB and Toxicology Unit, Pharmacology, Toxicology and Therapeutical Chemistry Department, Faculty of Pharmacy, University of Barcelona, 08028 Barcelona, SpainIn this study, our aims were to characterize oligodendrogenesis alterations in fetuses with intrauterine growth restriction (IUGR) and to find therapeutic strategies to prevent/treat them using a novel rabbit in vitro neurosphere culture. IUGR was surgically induced in one uterine horn of pregnant rabbits, while the contralateral horn served as a control. Neural progenitor cells (NPCs) were obtained from pup’s whole brain and cultured as neurospheres mimicking the basic processes of brain development including migration and cell differentiation. Five substances, chosen based on evidence provided in the literature, were screened in vitro in neurospheres from untreated rabbits: Docosahexaenoic acid (DHA), melatonin (MEL), zinc, 3,3′,5-Triiodo-L-thyronine (T3), and lactoferrin (LF) or its metabolite sialic acid (SA). DHA, MEL and LF were further selected for in vivo administration and subsequent evaluation in the Neurosphere Assay. In the IUGR culture, we observed a significantly reduced percentage of oligodendrocytes (OLs) which correlated with clinical findings indicating white matter injury in IUGR infants. We identified DHA and MEL as the most effective therapies. In all cases, our in vitro rabbit neurosphere assay predicted the outcome of the in vivo administration of the therapies and confirmed the reliability of the model, making it a powerful and consistent tool to select new neuroprotective therapies.https://www.mdpi.com/2227-9059/10/5/1205progenitor cellscell culturedifferentiationoligodendrocytesnervous system developmentneurogenesis
spellingShingle Britta Anna Kühne
Paula Vázquez-Aristizabal
Mercè Fuentes-Amell
Laura Pla
Carla Loreiro
Jesús Gómez-Catalán
Eduard Gratacós
Miriam Illa
Marta Barenys
Docosahexaenoic Acid and Melatonin Prevent Impaired Oligodendrogenesis Induced by Intrauterine Growth Restriction (IUGR)
Biomedicines
progenitor cells
cell culture
differentiation
oligodendrocytes
nervous system development
neurogenesis
title Docosahexaenoic Acid and Melatonin Prevent Impaired Oligodendrogenesis Induced by Intrauterine Growth Restriction (IUGR)
title_full Docosahexaenoic Acid and Melatonin Prevent Impaired Oligodendrogenesis Induced by Intrauterine Growth Restriction (IUGR)
title_fullStr Docosahexaenoic Acid and Melatonin Prevent Impaired Oligodendrogenesis Induced by Intrauterine Growth Restriction (IUGR)
title_full_unstemmed Docosahexaenoic Acid and Melatonin Prevent Impaired Oligodendrogenesis Induced by Intrauterine Growth Restriction (IUGR)
title_short Docosahexaenoic Acid and Melatonin Prevent Impaired Oligodendrogenesis Induced by Intrauterine Growth Restriction (IUGR)
title_sort docosahexaenoic acid and melatonin prevent impaired oligodendrogenesis induced by intrauterine growth restriction iugr
topic progenitor cells
cell culture
differentiation
oligodendrocytes
nervous system development
neurogenesis
url https://www.mdpi.com/2227-9059/10/5/1205
work_keys_str_mv AT brittaannakuhne docosahexaenoicacidandmelatoninpreventimpairedoligodendrogenesisinducedbyintrauterinegrowthrestrictioniugr
AT paulavazquezaristizabal docosahexaenoicacidandmelatoninpreventimpairedoligodendrogenesisinducedbyintrauterinegrowthrestrictioniugr
AT mercefuentesamell docosahexaenoicacidandmelatoninpreventimpairedoligodendrogenesisinducedbyintrauterinegrowthrestrictioniugr
AT laurapla docosahexaenoicacidandmelatoninpreventimpairedoligodendrogenesisinducedbyintrauterinegrowthrestrictioniugr
AT carlaloreiro docosahexaenoicacidandmelatoninpreventimpairedoligodendrogenesisinducedbyintrauterinegrowthrestrictioniugr
AT jesusgomezcatalan docosahexaenoicacidandmelatoninpreventimpairedoligodendrogenesisinducedbyintrauterinegrowthrestrictioniugr
AT eduardgratacos docosahexaenoicacidandmelatoninpreventimpairedoligodendrogenesisinducedbyintrauterinegrowthrestrictioniugr
AT miriamilla docosahexaenoicacidandmelatoninpreventimpairedoligodendrogenesisinducedbyintrauterinegrowthrestrictioniugr
AT martabarenys docosahexaenoicacidandmelatoninpreventimpairedoligodendrogenesisinducedbyintrauterinegrowthrestrictioniugr